Paula Morrison

发表

ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer

T. Powles, Robert J. Jones, S. Crabb, 2020, Trials.

ATLANTIS: An adaptive multi-arm phase II trial of maintenance targeted therapy after chemotherapy in patients with metastatic urothelial cancer

T. Powles, Robert J. Jones, S. Crabb, 2019 .

Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

J. Graham, D. Gaya, J. Edwards, 2021, Radiation oncology.

Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.

P. Mark, I. Macpherson, Jeff White, 2014, European journal of cancer.